Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Unum Therapeutics
Biotech
Bayer's BlueRock promotes CSO to CEO, president roles
Parkinson's disease biotech BlueRock Therapeutics, owned by Bayer, promoted Chief Scientific Officer Seth Ettenberg, Ph.D., to CEO and president.
Kyle LaHucik
Jul 26, 2021 11:23am
Unum's CAR-T tech lands at Czech biotech Sotio in $8.1M deal
Aug 31, 2020 8:30am
Days after wielding the ax, Unum hit with clinical hold, again
Mar 10, 2020 7:30am
Unum dumps clinical work, slashes 60% of workforce as CSO walks
Mar 2, 2020 11:11am
FDA puts Unum T cell therapy trial on hold after adverse events
Jul 3, 2019 10:52am
Unum IPO hits bottom of range, nets $62M for cancer trials
Mar 29, 2018 9:15am